Komori
Qol Holdings (3034) · InitiativeAdvanced

Enhancing Home Healthcare and Regional Healthcare Coordination

First written in FY2016. 14 of 21 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-09-30.

21entries
11years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017RestatedFY2023-Q2 – FY2024-Q32016: 320162017: 220172018: 020182019: 020192020: 020202021: 320212022: 420222023: 120232024: 120242025: 120252026: 62026
Same theme, other companies
Strengthening primary care pharmacy functions and advancing integrated community care and home healthcareA theme 14 companies write about · 0 as a headwind · 23 as a tailwind

The whole theme swung hardest in 2025: 1 of 10 companies on the "Worse" side.

9 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AdvancedAnnual report

    「In addition, in October 2025, we acquired the shares of Yokohama Yakugyo Service Co., Ltd., which actively engages in home dispensing. We will continue to make greater efforts to deliver patient-centered care through strategic initiatives in home and institutional dispensing.」

    In October 2025, we acquired Yokohama Yakugyo Service Co., Ltd., which engages in home dispensing, and continue to pursue a policy of strengthening regional healthcare through home and institutional dispensing.
  2. FY2024-Q3RestatedAnnual report

    「In pharmacy operations, we are working to provide home dispensing at all stores and significantly increase the number of facilities we serve by expanding stores specializing in home care as part of home and institutional dispensing, a new business pillar.」

    We continue to pursue the provision of home dispensing at all stores, increase the number of stores specializing in home care, and expand the number of facilities served.
  3. FY2023-Q3RestatedAnnual report

    「In pharmacy operations, we are working to address social needs and improve user convenience, while pursuing higher-quality pharmacy operations through the active expansion of home and institutional dispensing, which has been a new business pillar since the previous fiscal year, and the enhancement of the “Qol O-kusuri-bin (LINE Mini App)” service.」

    We continue to actively expand home and institutional dispensing and improve convenience by enhancing the functions of Qol O-kusuri-bin.
  4. FY2023-Q2RestatedAnnual report

    「In pharmacy operations, we are promoting home and institutional dispensing, which has been a new business pillar since the previous fiscal year. We are working to provide home dispensing at all stores and actively developing stores specializing in home care to address social needs.」

    We continue to work toward providing home dispensing at all stores and developing stores specializing in home care.
  5. FY2023-Q1AdvancedAnnual report

    「Regarding home and institutional dispensing, which we have promoted as a new business pillar since the previous fiscal year, we will work toward providing home dispensing at all stores and significantly increase the number of facilities we serve by expanding the number of stores specializing in home care.」

    The company outlined specific plans for home and institutional dispensing, including providing home dispensing at all stores, increasing the number of stores specializing in home care, and significantly expanding the number of facilities served.
  6. FY2022RestatedAnnual report

    「In the health insurance pharmacy business, we are pursuing active M&A and new store openings, as well as promoting home and institutional dispensing as a new business pillar, thereby establishing a system that contributes to the stabilization of regional healthcare and improved patient convenience.」

    We continue to pursue the stabilization of regional healthcare by making home and institutional dispensing a new business pillar alongside M&A and new store openings.
  7. FY2022-Q3AdvancedAnnual report

    「Regarding the promotion of home and institutional dispensing, our efforts to develop pharmacies specializing in home healthcare resulted in our receiving the Nikkei Excellent Products and Services Awards Nikkei MJ Award, the first such award in the dispensing pharmacy industry.」

    We worked to develop pharmacies specializing in home healthcare and received the Nikkei MJ Award, the first such award in the dispensing pharmacy industry.
  8. FY2022-Q2AdvancedAnnual report

    「In addition, we are promoting home and institutional dispensing as a new business pillar. As a result of sales activities targeting operators of facilities such as paid nursing homes and cooperation with medical institutions, sales and the number of prescriptions processed have remained firm. At our health insurance pharmacies, we are focusing on delivering patient-centered care through strategic measures such as having core home-care stores coordinate and support facilities and individual stores, while also selling daily necessities during facility visits to improve convenience. Going forward, we aim to expand specialized home-care stores across wider areas by strengthening relationships with facility operators and further promote home and institutional dispensing.」

    As a result of advancing sales activities targeting facility operators, cooperation with medical institutions, and coordination and support by core home-care stores, sales and the number of prescriptions processed remained firm. The company also outlined the expansion of specialized home-care stores across wider areas by strengthening relationships with facility operators.
  9. FY2022-Q1AdvancedAnnual report

    「In addition, we are promoting home and institutional dispensing as a new business pillar. As a result of sales activities targeting operators of facilities such as paid nursing homes and cooperation with medical institutions, sales and the number of prescriptions processed have remained firm. At our health insurance pharmacies, we are focusing on delivering patient-centered care through strategic measures such as having core home-care stores coordinate and support facilities and individual stores.」

    Home and institutional dispensing was promoted as a new business pillar. As a result of sales activities targeting facility operators, cooperation with medical institutions, and coordination and support by core home-care stores, sales and the number of prescriptions processed remained firm.
  10. FY2021AdvancedAnnual report

    「In the health insurance pharmacy business, we will promote home and institutional dispensing as a new business pillar. At our health insurance pharmacies, we will focus on delivering patient-centered care by taking strategic measures such as designating core home-care stores to coordinate and support facilities and individual stores.」

    The company positioned home and institutional dispensing as a new business pillar and outlined plans to advance coordination and support between facilities and stores through core home-care stores.
  11. FY2017RestatedAnnual report

    「In addition, to respond promptly to the “Pharmacy Vision for Patients,” we established a model health support pharmacy and are promoting health seminars for local residents and self-medication for pre-disease conditions through the use of ICT.」

    We continue to hold health seminars for local residents and address preclinical conditions using ICT.
  12. FY2017-Q3AdvancedAnnual report

    「We established a model health-support pharmacy and have promoted health seminars for local residents and self-medication for preclinical conditions using ICT.」

    The company specifically outlined health seminars for local residents and the promotion of self-medication and measures for preclinical conditions using ICT.
  13. FY2017-Q2AdvancedAnnual report

    「By combining the strengths of both companies, including the concept of “health-support pharmacies,” the provision of regional healthcare services required of “family pharmacists” under this fiscal year's medical fee revision, responses to challenges and changes in social structures, and improvements in the qualities and capabilities of pharmacists and other personnel, we believe we can create new added value and enhance our contribution to healthcare and health.」

    Through the business combination with Kyoeido, the company indicated its intention to combine both companies' strengths in health-support pharmacies, family pharmacists, regional healthcare services, and personnel development.
  14. FY2017-Q1AdvancedAnnual report

    「We operate pharmacies in various formats, including “Machinaka” pharmacies developed through the industry's first collaboration with companies in other industries, as well as “Ekichika” and “Ekinaka” pharmacies.」

    We are expanding points of contact with local communities by operating “Machinaka” pharmacies and other formats developed through collaboration with companies in other industries.
  15. FY2016First statedAnnual report

    「We will strengthen cooperation with regional healthcare providers and companies in other industries and fulfill the role expected of our group.」

    The company has identified cooperation with regional healthcare providers and companies in other industries as a strategic initiative.
Moved together

"Business Expansion Through M&A" moved the same way as this thread, in the same document, in 13 of its 21 moves.

131010988★123456
  1. ★This thread
  2. 1Business Expansion Through M&A13×
  3. 2Expansion of Store Count, Including Acquisitions10×
  4. 3Improving Market Share by Increasing Staffing in the CSO Business10×
  5. 4Improving Convenience Through ICT9×
  6. 5Strengthening the Functions of Primary-Care Pharmacists and Pharmacies8×
  7. 6Track Record of Expanding the Health Insurance Pharmacy Network8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the M&A and Subsidiary Changes of 2026-09-30: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Home Healthcare and Regional Healthcare Coordination | Qol Holdings Co.,Ltd. (3034) | Komori